Item Type | Name |
Academic Article
|
Galectin-3 expression is associated with tumor progression and pattern of sun exposure in melanoma.
|
Academic Article
|
The low molecular weight cyclin E isoforms augment angiogenesis and metastasis of human melanoma cells in vivo.
|
Academic Article
|
A fully human antimelanoma cellular adhesion molecule/MUC18 antibody inhibits spontaneous pulmonary metastasis of osteosarcoma cells in vivo.
|
Concept
|
Neoplasm Metastasis
|
Concept
|
Lymphatic Metastasis
|
Academic Article
|
Targeting melanoma growth and metastasis with systemic delivery of liposome-incorporated protease-activated receptor-1 small interfering RNA.
|
Academic Article
|
PAR-1 and thrombin: the ties that bind the microenvironment to melanoma metastasis.
|
Academic Article
|
Transcriptional control of melanoma metastasis: the importance of the tumor microenvironment.
|
Academic Article
|
Protease activated receptor-1 inhibits the Maspin tumor-suppressor gene to determine the melanoma metastatic phenotype.
|
Academic Article
|
Emerging roles of PAR-1 and PAFR in melanoma metastasis.
|
Academic Article
|
The emerging role of the thrombin receptor (PAR-1) in melanoma metastasis--a possible therapeutic target.
|
Academic Article
|
Expression of Id-1 is regulated by MCAM/MUC18: a missing link in melanoma progression.
|
Academic Article
|
Phosphorylated epidermal growth factor receptor on tumor-associated endothelial cells is a primary target for therapy with tyrosine kinase inhibitors.
|
Academic Article
|
Src activation by ?-adrenoreceptors is a key switch for tumour metastasis.
|
Academic Article
|
Silencing cAMP-response element-binding protein (CREB) identifies CYR61 as a tumor suppressor gene in melanoma.
|
Academic Article
|
Overexpression of protease-activated receptor-1 contributes to melanoma metastasis via regulation of connexin 43.
|
Academic Article
|
Crosstalk between protease-activated receptor 1 and platelet-activating factor receptor regulates melanoma cell adhesion molecule (MCAM/MUC18) expression and melanoma metastasis.
|
Academic Article
|
Tumor immunotherapy in melanoma: strategies for overcoming mechanisms of resistance and escape.
|
Academic Article
|
CREB inhibits AP-2alpha expression to regulate the malignant phenotype of melanoma.
|
Academic Article
|
Ultraviolet B irradiation promotes tumorigenic and metastatic properties in primary cutaneous melanoma via induction of interleukin 8.
|
Academic Article
|
Loss of AP-2 results in downregulation of c-KIT and enhancement of melanoma tumorigenicity and metastasis.
|
Academic Article
|
Dominant-negative transcription factor AP-2 augments SB-2 melanoma tumor growth in vivo.
|
Academic Article
|
Fully humanized neutralizing antibodies to interleukin-8 (ABX-IL8) inhibit angiogenesis, tumor growth, and metastasis of human melanoma.
|
Academic Article
|
Role and regulation of the thrombin receptor (PAR-1) in human melanoma.
|
Academic Article
|
Fully human anti-interleukin 8 antibody inhibits tumor growth in orthotopic bladder cancer xenografts via down-regulation of matrix metalloproteases and nuclear factor-kappaB.
|
Academic Article
|
Regulation of KiSS-1 metastasis suppressor gene expression in breast cancer cells by direct interaction of transcription factors activator protein-2alpha and specificity protein-1.
|
Academic Article
|
ACTIBIND, a T2 RNase, competes with angiogenin and inhibits human melanoma growth, angiogenesis, and metastasis.
|
Academic Article
|
Terminal differentiation and apoptosis in experimental lung metastases of human osteogenic sarcoma cells by wild type p53.
|
Academic Article
|
Direct correlation between MUC18 expression and metastatic potential of human melanoma cells.
|
Academic Article
|
Molecular mechanisms of melanoma metastasis.
|
Academic Article
|
Molecular changes in human melanoma metastasis.
|
Academic Article
|
Role of AP-2 in tumor growth and metastasis of human melanoma.
|
Academic Article
|
Interleukin 8 expression regulates tumorigenicity and metastasis in human bladder cancer.
|
Academic Article
|
Transcriptional regulation of metastasis-related genes in human melanoma.
|
Academic Article
|
Inflammation and melanoma growth and metastasis: the role of platelet-activating factor (PAF) and its receptor.
|
Academic Article
|
The HOG-GLI face of melanoma.
|
Academic Article
|
A subset of host B lymphocytes controls melanoma metastasis through a melanoma cell adhesion molecule/MUC18-dependent interaction: evidence from mice and humans.
|
Academic Article
|
Expression profiling of Galectin-3-depleted melanoma cells reveals its major role in melanoma cell plasticity and vasculogenic mimicry.
|
Academic Article
|
Searching for the 'melano-miRs': miR-214 drives melanoma metastasis.
|
Academic Article
|
Driving transcriptional regulators in melanoma metastasis.
|
Academic Article
|
Why is melanoma so metastatic?
|
Academic Article
|
The relationship between MHC antigen expression and metastasis.
|
Academic Article
|
NK sensitivity, H-2, c-K-ras proto-oncogene expression and metastases: analysis of the metastatic potential of H-2 gene transfected fibrosarcoma cells.
|
Academic Article
|
Association in the expression of Kirsten-ras oncogene and the major histocompatibility complex class I antigens in fibrosarcoma tumor cell variants exhibiting different metastatic capabilities.
|
Academic Article
|
Suppression of tumor growth and metastasis of murine renal adenocarcinoma by syngeneic fibroblasts genetically engineered to secrete the JE/MCP-1 cytokine.
|
Academic Article
|
Expression of the JE/MCP-1 gene suppresses metastatic potential in murine colon carcinoma cells.
|
Academic Article
|
Expression of MCAM/MUC18 by human melanoma cells leads to increased tumor growth and metastasis.
|
Academic Article
|
Dominant-negative CREB inhibits tumor growth and metastasis of human melanoma cells.
|
Academic Article
|
Loss of AP-2 results in up-regulation of MCAM/MUC18 and an increase in tumor growth and metastasis of human melanoma cells.
|
Academic Article
|
Interleukin 10 suppresses tumor growth and metastasis of human melanoma cells: potential inhibition of angiogenesis.
|
Academic Article
|
Role of interleukin-8 in tumor growth and metastasis of human melanoma.
|
Academic Article
|
Regulation of tumor growth and metastasis by interleukin-10: the melanoma experience.
|
Academic Article
|
Interleukin 8 expression regulates tumorigenicity and metastases in androgen-independent prostate cancer.
|
Academic Article
|
Inhibition of tumor growth and metastasis of human melanoma by intracellular anti-ATF-1 single chain Fv fragment.
|
Academic Article
|
Regulation of tumor growth and metastasis of human melanoma by the CREB transcription factor family.
|
Academic Article
|
Gene regulation in melanoma progression by the AP-2 transcription factor.
|
Academic Article
|
Cellular adhesion pathways and metastatic potential of human melanoma.
|
Academic Article
|
Nuclear factor-kappaB mediates angiogenesis and metastasis of human bladder cancer through the regulation of interleukin-8.
|
Academic Article
|
Inhibition of tumorigenicity and metastasis of human melanoma cells by anti-cathepsin L single chain variable fragment.
|
Academic Article
|
Exposure of melanoma cells to dacarbazine results in enhanced tumor growth and metastasis in vivo.
|
Academic Article
|
Construction and expression of intracellular anti-ATF-1 single chain Fv fragment: a modality to inhibit melanoma tumor growth and metastasis.
|
Academic Article
|
Up-regulation of Flotillin-2 is associated with melanoma progression and modulates expression of the thrombin receptor protease activated receptor 1.
|
Academic Article
|
Immunization against MUC18/MCAM, a novel antigen that drives melanoma invasion and metastasis.
|
Academic Article
|
Tumor progression and metastasis from genetic to microenvironmental determinants: a workshop of the tumor progression and metastasis NIH study section in honor of Dr. Martin L. Padarathsingh, May 31, 2006, Georgetown, Washington, DC.
|
Academic Article
|
EphA2 overexpression promotes ovarian cancer growth.
|
Academic Article
|
Transcriptional control of the melanoma malignant phenotype.
|
Academic Article
|
Inflammation and melanoma metastasis.
|
Academic Article
|
Stress effects on FosB- and interleukin-8 (IL8)-driven ovarian cancer growth and metastasis.
|
Academic Article
|
Crossing the junction in the gap of melanoma brain metastasis.
|
Academic Article
|
Influence of H-2K transfection on susceptibility of fibrosarcoma tumor cells to natural killer (NK) cells.
|
Academic Article
|
A cysteine proteinase, which cleaves human C3, the third component of complement, is involved in tumorigenicity and metastasis of human melanoma.
|
Academic Article
|
Expression of interleukin-8 by human melanoma cells up-regulates MMP-2 activity and increases tumor growth and metastasis.
|
Academic Article
|
Fully human antibodies to MCAM/MUC18 inhibit tumor growth and metastasis of human melanoma.
|
Academic Article
|
Platelet-activating factor mediates MMP-2 expression and activation via phosphorylation of cAMP-response element-binding protein and contributes to melanoma metastasis.
|
Academic Article
|
Lysophosphatidic acid induces lymphangiogenesis and IL-8 production in vitro in human lymphatic endothelial cells.
|
Academic Article
|
Galectin-3 contributes to melanoma growth and metastasis via regulation of NFAT1 and autotaxin.
|
Academic Article
|
Abnormalities in the CDKN2 (p16INK4/MTS-1) gene in human melanoma cells: relevance to tumor growth and metastasis.
|
Academic Article
|
p53 gene mutation spectrum in human unknown primary tumors.
|
Academic Article
|
Transcriptional regulation of KiSS-1 gene expression in metastatic melanoma by specificity protein-1 and its coactivator DRIP-130.
|
Academic Article
|
The metastatic microenvironment: Claudin-1 suppresses the malignant phenotype of melanoma brain metastasis.
|
Academic Article
|
NFAT1 directly regulates IL8 and MMP3 to promote melanoma tumor growth and metastasis
|
Academic Article
|
Preclinical drug development must consider the impact on metastasis
|
Academic Article
|
Crossing the junction in the gap of melanoma brain metastasis
|